Literature DB >> 21509436

Lymph node-based disease and HHV-8/KSHV infection in HIV seronegative patients: report of three new cases of a heterogeneous group of diseases.

Antonio D'Antonio1, Maria Addesso2, Domenico Memoli3, Pina Liguori4, Roberto Cuomo5, Amedeo Boscaino6, Oscar Nappi6.   

Abstract

We describe three cases of lymph proliferative diseases characterized by the presence of lymphoma cells expressing the KSHV/HHV-8 antigen with or without EBV expression. The patients were HIV seronegative without serous effusions. One case was diagnosed as KSHV-germinotropic lymphoproliferative disorder due to the presence of atypical plasmablasts involving germinal centers. These plasmablasts were positive for MUM1 and vIL6, co-expressed EBV and LNA-1 of HHV-8/KSHV, and showed a polyclonal pattern of Ig gene rearrangements on PCR. The disease was localized and the prognosis was good. In two other cases, a diagnosis of KSHV/HHV-8-related diffuse large cell B-lymphoma morphology was made. The lymphoma cells were anaplastic or frankly pleomorphic, expressed KSHV but not EBV, and were positive for CD20, MUM1, PAX-5, and vIL6. In both cases the prognosis was poor. On the basis of the features observed, we raise three considerations: (1) KSHV-related lymphoproliferative disorders represent a distinctive and heterogeneous group of diseases with variable clinico-pathologic findings and immunophenotypes (BCL6-/MUM1+/CD138- and BCL6+/MUM1+/CD138- or BCL6-/MUM1+/CD138+). (2) Although the pathogenic mechanism of HHV8 in lymphomagenesis is unclear, the presence the viral DNA in lymph nodes of HIV- patients is not a simply opportunistic infection, but is directly implicated in the pathogenesis of KSHV-related diseases; the activation of IL-6 receptor signalling may play an important role in most cases. (3) The different prognoses among different diseases with KSHV etiology may be related to the fact that the pathogenic potential appears to be constrained by a competent immune system.

Entities:  

Mesh:

Year:  2011        PMID: 21509436     DOI: 10.1007/s12185-011-0849-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  26 in total

1.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Authors:  R G Nador; E Cesarman; A Chadburn; D B Dawson; M Q Ansari; J Sald; D M Knowles
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

2.  Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma.

Authors:  J Teruya-Feldstein; P Zauber; J E Setsuda; E L Berman; L Sorbara; M Raffeld; G Tosato; E S Jaffe
Journal:  Lab Invest       Date:  1998-12       Impact factor: 5.662

Review 3.  Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature.

Authors:  Hailing Zhang; Xiao Yan Yang; Tao Hong; Tatyana Feldman; Pritish K Bhattacharyya
Journal:  Acta Haematol       Date:  2010-05-19       Impact factor: 2.195

4.  Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization.

Authors:  J G Howe; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Castleman disease in an HIV-infected patient with Kaposi sarcoma.

Authors:  M W Saif
Journal:  AIDS Read       Date:  2001-11

6.  Early peripheral lymph node involvement of human herpesvirus 8-associated, body cavity-based lymphoma in a human immunodeficiency virus-negative patient.

Authors:  S Ariad; D Benharroch; L Lupu; B Davidovici; N Dupin; C Boshoff
Journal:  Arch Pathol Lab Med       Date:  2000-05       Impact factor: 5.534

7.  PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases.

Authors:  C Thériault; S Galoin; S Valmary; J Selves; L Lamant; D Roda; F Rigal-Huguet; P Brousset; G Delsol; T Al Saati
Journal:  Mod Pathol       Date:  2000-12       Impact factor: 7.842

Review 8.  KSHV/HHV8-associated lymphomas.

Authors:  Antonino Carbone; Annunziata Gloghini
Journal:  Br J Haematol       Date:  2007-11-07       Impact factor: 6.998

9.  Human herpesvirus 8 in primary effusion lymphoma in an HIV-seronegative male. A case report.

Authors:  Mariana Munichor; Hector Cohen; Ronit Sarid; Irena Manov; Theodore C Iancu
Journal:  Acta Cytol       Date:  2004 May-Jun       Impact factor: 2.319

10.  KSHV- and EBV-associated germinotropic lymphoproliferative disorder: a rare lymphoproliferative disease of HIV patient with plasmablastic morphology, indolent course and favourable response to therapy.

Authors:  Antonio D'Antonio; D'Antonio Antonio; Amedeo Boscaino; Boscaino Amedeo; Maria Addesso; Addesso Maria; Miguel Angel Piris; Piris Miguel Angel; Oscar Nappi; Nappi Oscar
Journal:  Leuk Lymphoma       Date:  2007-07
View more
  3 in total

Review 1.  Multicentric Castleman disease: Where are we now?

Authors:  Hao-Wei Wang; Stefania Pittaluga; Elaine S Jaffe
Journal:  Semin Diagn Pathol       Date:  2016-05-16       Impact factor: 3.464

2.  HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome.

Authors:  Dhouha Bacha; Beya Chelly; Houda Kilani; Lamia Charfi; Amel Douggaz; Samia Chatti; Emna Chelbi
Journal:  Case Rep Hematol       Date:  2017-02-09

Review 3.  Human herpes virus 8-positive germinotropic lymphoproliferative disorder: first case diagnosed in the UK, literature review and discussion of treatment options.

Authors:  Ahmed Ghoneima; Joanna Cooke; Emily Shaw; Avi Agrawal
Journal:  BMJ Case Rep       Date:  2020-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.